LUMICAIN- aluminium chloride hexahydrate solution

lumicain by

Drug Labeling and Warnings

lumicain by is a Prescription medication manufactured, distributed, or labeled by Medical Products Laboratories, Inc.. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

DOSAGE & ADMINISTRATION

FOR TOPICAL APPLICATION ONLY

For Granulation Tissue Growth: Allow packing saturated in Lumicain to remain in nail groove for 48 hours; repeat if necessary.

If hemmorrhage is profuse, dress wound with gauze saturated with Lumicain and allow to remain for 24 hours or longer.

WARNINGS AND PRECAUTIONS

CAUTION: Federal Law restricts sale and use to physician or licensed practitioner.

PRINCIPAL DISPLAY PANEL

premier lumicainTM Topical Hemostatic Solution 60cc

For Rapid Control of Minor Hemorrhage

Each Gram Contains: Aluminium Chloride............250 mg.

In an aqueous base.

Enter section text here

INGREDIENTS AND APPEARANCE

LUMICAIN 
aluminium chloride hexahydrate solution

Product Information
Product Type	HUMAN PRESCRIPTION DRUG	Item Code (Source)	NDC: 10733-412
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
ALUMINUM CHLORIDE (UNII: 3CYT62D3GA) (ALUMINUM - UNII:CPD4NFA903)	ALUMINUM CHLORIDE	250 mg  in 1 g

Inactive Ingredients
Ingredient Name	Strength
WATER (UNII: 059QF0KO0R)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 10733-412-60	67 g in 1 BOTTLE

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
unapproved drug other		09/29/2010

Labeler - Medical Products Laboratories, Inc. (002290302)

Registrant - Medical Products Laboratories, Inc. (002290302)

Establishment
Name	Address	ID/FEI	Business Operations
Medical Products Laboratories, Inc.		002290302	analysis, manufacture, label, pack